MedTech Dive February 28, 2025
Nick Paul Taylor

Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for interventions like TAVR.

Dive Brief:

  • Medtronic has struck a deal to accelerate adoption of Brainomix’s artificial intelligence-powered tool for assessing stroke patients.
  • The agreement, which Brainomix disclosed Thursday, positions Medtronic to use its presence in Western Europe to support the rollout of the technology in the region.
  • Medtronic has connections to hospitals and healthcare providers that treat stroke patients in the region through its distribution of devices, according to the announcement, such as its Solitaire clot retrieval devices.

Dive Insight:

The Brainomix 360 Stroke platform, formerly called e-Stroke, uses AI-derived algorithms to analyze CT brain scans. The algorithms detect acute...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Medical Devices, Partnerships, Technology, Trends
Related Articles:
Phillips launches updated AI tech for MRI scanners
Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces
Building Solid Relationships with Universities Critical for Early Stage Medtech Investors
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions
Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment

Share This Article